These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25008355)

  • 1. ESCRT-mediated uptake and degradation of brain-targeted α-synuclein single chain antibody attenuates neuronal degeneration in vivo.
    Spencer B; Emadi S; Desplats P; Eleuteri S; Michael S; Kosberg K; Shen J; Rockenstein E; Patrick C; Adame A; Gonzalez T; Sierks M; Masliah E
    Mol Ther; 2014 Oct; 22(10):1753-67. PubMed ID: 25008355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease.
    Spencer B; Kim C; Gonzalez T; Bisquertt A; Patrick C; Rockenstein E; Adame A; Lee SJ; Desplats P; Masliah E
    Hum Mol Genet; 2016 Mar; 25(6):1100-15. PubMed ID: 26740557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease.
    Spencer B; Trinh I; Rockenstein E; Mante M; Florio J; Adame A; El-Agnaf OMA; Kim C; Masliah E; Rissman RA
    Neurobiol Dis; 2019 Jul; 127():163-177. PubMed ID: 30849508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy.
    Spencer B; Valera E; Rockenstein E; Overk C; Mante M; Adame A; Zago W; Seubert P; Barbour R; Schenk D; Games D; Rissman RA; Masliah E
    Acta Neuropathol Commun; 2017 Jan; 5(1):7. PubMed ID: 28086964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity.
    Gupta V; Salim S; Hmila I; Vaikath NN; Sudhakaran IP; Ghanem SS; Majbour NK; Abdulla SA; Emara MM; Abdesselem HB; Lukacsovich T; Erskine D; El-Agnaf OMA
    Sci Rep; 2020 May; 10(1):8137. PubMed ID: 32424162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.
    Spencer B; Potkar R; Trejo M; Rockenstein E; Patrick C; Gindi R; Adame A; Wyss-Coray T; Masliah E
    J Neurosci; 2009 Oct; 29(43):13578-88. PubMed ID: 19864570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.
    Kim C; Kwon S; Iba M; Spencer B; Rockenstein E; Mante M; Adame A; Shin SJ; Fields JA; Rissman RA; Lee SJ; Masliah E
    Exp Mol Med; 2021 Feb; 53(2):281-290. PubMed ID: 33594256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease.
    Davies SE; Hallett PJ; Moens T; Smith G; Mangano E; Kim HT; Goldberg AL; Liu JL; Isacson O; Tofaris GK
    Neurobiol Dis; 2014 Apr; 64(100):79-87. PubMed ID: 24388974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo.
    Rockenstein E; Nuber S; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Trejo-Morales M; Gerez J; Picotti P; Jensen PH; Campioni S; Riek R; Winkler J; Gage FH; Winner B; Masliah E
    Brain; 2014 May; 137(Pt 5):1496-513. PubMed ID: 24662516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification and characterization of α-synuclein fibrillar specific scFv from inclusion bodies.
    Gupta V; Sudhakaran IP; Islam Z; Vaikath NN; Hmila I; Lukacsovich T; Kolatkar PR; El-Agnaf OMA
    PLoS One; 2020; 15(11):e0241773. PubMed ID: 33156828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-synuclein buildup is alleviated via ESCRT-dependent endosomal degradation brought about by p38MAPK inhibition in cells expressing p25α.
    Borland H; Rasmussen I; Bjerregaard-Andersen K; Rasmussen M; Olsen A; Vilhardt F
    J Biol Chem; 2022 Nov; 298(11):102531. PubMed ID: 36162505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered antibody therapies coming of age for aging brains.
    Messer A
    Mol Ther; 2014 Oct; 22(10):1725-7. PubMed ID: 25269943
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models.
    Games D; Valera E; Spencer B; Rockenstein E; Mante M; Adame A; Patrick C; Ubhi K; Nuber S; Sacayon P; Zago W; Seubert P; Barbour R; Schenk D; Masliah E
    J Neurosci; 2014 Jul; 34(28):9441-54. PubMed ID: 25009275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endosomal sorting related protein CHMP2B is localized in Lewy bodies and glial cytoplasmic inclusions in α-synucleinopathy.
    Tanikawa S; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
    Neurosci Lett; 2012 Oct; 527(1):16-21. PubMed ID: 22947304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Henrich MT; Geibl FF; Lee B; Chiu WH; Koprich JB; Brotchie JM; Timmermann L; Decher N; Matschke LA; Oertel WH
    Acta Neuropathol Commun; 2018 May; 6(1):39. PubMed ID: 29747690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission.
    Bae EJ; Lee HJ; Rockenstein E; Ho DH; Park EB; Yang NY; Desplats P; Masliah E; Lee SJ
    J Neurosci; 2012 Sep; 32(39):13454-69. PubMed ID: 23015436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein aggregation alters tyrosine hydroxylase phosphorylation and immunoreactivity: lessons from viral transduction of knockout mice.
    Alerte TN; Akinfolarin AA; Friedrich EE; Mader SA; Hong CS; Perez RG
    Neurosci Lett; 2008 Apr; 435(1):24-9. PubMed ID: 18314273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.
    Spencer B; Desplats PA; Overk CR; Valera-Martin E; Rissman RA; Wu C; Mante M; Adame A; Florio J; Rockenstein E; Masliah E
    J Neurosci; 2016 Jul; 36(30):7971-84. PubMed ID: 27466341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies.
    Price DL; Rockenstein E; Mante M; Adame A; Overk C; Spencer B; Duong-Polk KX; Bonhaus D; Lindsey J; Masliah E
    Sci Rep; 2016 Jul; 6():29523. PubMed ID: 27389831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.